UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

537 Absolute quantitation of MET using mass spectrometry for clinical application: assay precision, stability, and correlation with MET gene amplification in FFPE tumor tissue

European journal of cancer (1990), 2014-11, Vol.50, p.175-175

2014

Volltextzugriff (PDF)

811PDMET TUMOR EXPRESSION AND MUTATIONAL ANALYSIS IN BLADDER CANCER PATIENTS (PTS) RECEIVING CABOZANTINIB

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv281-iv281

2014

Volltextzugriff (PDF)

Control of recombinant human endostatin production in fed-batch cultures of Pichia pastoris using the methanol feeding rate

Biotechnology letters, 2002-10, Vol.24 (19), p.1631-1635

2002

Volltextzugriff (PDF)

Determination of Ligand-Binding Specificity by Alternative Splicing: Two Distinct Growth Factor Receptors Encoded by a Single Gene

Proceedings of the National Academy of Sciences - PNAS, 1992-01, Vol.89 (1), p.246-250

1992

Volltextzugriff (PDF)

Expression of biologically active recombinant keratinocyte growth factor. Structure/function analysis of amino-terminal truncation mutants

The Journal of biological chemistry, 1993-02, Vol.268 (4), p.2984-2988

1993

Volltextzugriff (PDF)

Final results of a phase I study of cabozantinib (cabo) plus nivolumab (nivo) and cabonivo plus ipilimumab (Ipi) in patients (pts) with metastatic urothelial carcinoma (mUC) and other genitourinary (GU) malignancies

Annals of oncology, 2017-09, Vol.28, p.v295-v295

2017

Volltextzugriff (PDF)

Identification and biochemical characterization of novel putative substrates for the epidermal growth factor receptor kinase

The Journal of biological chemistry, 1992-03, Vol.267 (8), p.5155-5161

1992

Volltextzugriff (PDF)

Identification of the Hepatocyte Growth Factor Receptor as the c-met Proto-Oncogene Product

Science (American Association for the Advancement of Science), 1991-02, Vol.251 (4995), p.802-804

1991

Volltextzugriff (PDF)

A keratinocyte growth factor receptor-derived peptide antagonist identifies part of the ligand binding site

The Journal of biological chemistry, 1993-05, Vol.268 (13), p.9180-9183

1993

Volltextzugriff (PDF)

LLM-PBC: Logic Learning Machine-based explainable rules accurately stratify the genetic risk of Primary Biliary Cholangitis

Digestive and liver disease, 2022-10, Vol.54, p.S169-S170

2022

Volltextzugriff (PDF)

Met Tumor Expression and Mutational Analysis in Bladder Cancer Patients (Pts) Receiving Cabozantinib

Annals of oncology, 2014-09, Vol.25, p.iv281

2014

Volltextzugriff (PDF)

A novel dual specificity phosphatase induced by serum stimulation and heat shock

The Journal of biological chemistry, 1994-11, Vol.269 (47), p.29897-29902

1994

Volltextzugriff (PDF)

A phase I study of cabozantinib plus nivolumab (CaboNivo) in patients (pts) refractory metastatic urothelial carcinoma (mUC) and other genitourinary (GU) tumors

Annals of oncology, 2016-10, Vol.27, p.vi266-vi266

2016

Volltextzugriff (PDF)

A phase II study of cabozantinib in patients (pts) with relapsed/refractory metastatic urothelial carcinoma (mUC)

Annals of oncology, 2016-10, Vol.27, p.vi272-vi272

2016

Volltextzugriff (PDF)

A single amino acid substitution is sufficient to modify the mitogenic properties of the epidermal growth factor receptor to resemble that of gp185erbB‐2

The EMBO journal, 1992-11, Vol.11 (11), p.3927-3933

1992

Volltextzugriff (PDF)

Synergistic anti-leukemic activity of imatinib in combination with a small molecule Grb2 SH2 domain binding antagonist

Leukemia, 2014-04, Vol.28 (4), p.948-951

2014

Volltextzugriff (PDF)

Urinary c-Met, a Novel Biomarker of Metastatic Prostate Cancer

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S57-S58

2008

Volltextzugriff (PDF)

Urinary c-Met Levels as an Indicator of Disease Progression in Glioblastoma Multiforme Patients

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S215-S215

2008

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(18)

Sprache

Englisch
(18)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

537 Absolute quantitation of MET using mass spectrometry for clinical application: assay precision, stability, and correlation with MET gene amplification in FFPE tumor tissue

811PDMET TUMOR EXPRESSION AND MUTATIONAL ANALYSIS IN BLADDER CANCER PATIENTS (PTS) RECEIVING CABOZANTINIB

Control of recombinant human endostatin production in fed-batch cultures of Pichia pastoris using the methanol feeding rate

Determination of Ligand-Binding Specificity by Alternative Splicing: Two Distinct Growth Factor Receptors Encoded by a Single Gene

Expression of biologically active recombinant keratinocyte growth factor. Structure/function analysis of amino-terminal truncation mutants

Final results of a phase I study of cabozantinib (cabo) plus nivolumab (nivo) and cabonivo plus ipilimumab (Ipi) in patients (pts) with metastatic urothelial carcinoma (mUC) and other genitourinary (GU) malignancies

Identification and biochemical characterization of novel putative substrates for the epidermal growth factor receptor kinase

Identification of the Hepatocyte Growth Factor Receptor as the c-met Proto-Oncogene Product

A keratinocyte growth factor receptor-derived peptide antagonist identifies part of the ligand binding site

LLM-PBC: Logic Learning Machine-based explainable rules accurately stratify the genetic risk of Primary Biliary Cholangitis

Met Tumor Expression and Mutational Analysis in Bladder Cancer Patients (Pts) Receiving Cabozantinib

A novel dual specificity phosphatase induced by serum stimulation and heat shock

A phase I study of cabozantinib plus nivolumab (CaboNivo) in patients (pts) refractory metastatic urothelial carcinoma (mUC) and other genitourinary (GU) tumors

A phase II study of cabozantinib in patients (pts) with relapsed/refractory metastatic urothelial carcinoma (mUC)

A single amino acid substitution is sufficient to modify the mitogenic properties of the epidermal growth factor receptor to resemble that of gp185erbB‐2

Synergistic anti-leukemic activity of imatinib in combination with a small molecule Grb2 SH2 domain binding antagonist

Urinary c-Met, a Novel Biomarker of Metastatic Prostate Cancer

Urinary c-Met Levels as an Indicator of Disease Progression in Glioblastoma Multiforme Patients

Suchergebnisse filtern